COVID-19 Updates

What to Know About the Reauthorized SBIR/STTR Grant Programs

What to Know About the Reauthorized SBIR/STTR Grant Programs
FDA Issues Final Guidance on Content of Premarket Submissions for Device Software Functions

On June 13, the U.S. Food and Drug Administration (FDA) issued the final guidance: Content of Premarket Submissions…
BioHive Takes the Stage at One Utah Summit

The BioHive community was featured prominently at the One Utah Summit held on May 10 at the Grand…
Recursion Co-Founder and CEO, Chris Gibson, Awarded Governor’s Medal for Science and Technology

Recursion Co-founder and CEO, Chris Gibson, Ph.D., was honored at the One Utah Summit on May 10, receiving…
Pfizer to Acquire Arena Pharmaceuticals

Pfizer and Arena Pharmaceutical on Dec. 13 announced that the companies have entered into an agreement under which…
U.S. Department of Labor’s Occupational Safety and Health Administration Unveils Rule to Mandate COVID-19 Vaccines for Large Employers

The Department of Labor’s Occupational Safety and Health Administration (OSHA) yesterday issued a rule requiring employers with 100…
Sumitomo Dainippon Pharma Oncology Announces First Patient Dosed in Phase 1 Study of DSP-0390 in Patients with Recurrent High-Grade Glioma

Sumitomo Dainippon Pharma Oncology (SDP Oncology), which has research facilities in Lehi, Utah, recently announced that the first…
Representative Moore Tours Utah Companies – BD, Edwards Lifesciences and Stryker

BioHive on Wednesday was front and center as U.S. Representative Blake Moore (R-UT-1) toured Edwards Lifesciences, BD and…
SkinTE® Met Primary and Secondary Endpoints in Final Analysis from Diabetic Foot Ulcer Trial

PolarityTE on July 28 announced final data from a multi-center randomized controlled trial evaluating treatment of Diabetic Foot…
PolarityTE Receives Notice of Allowance for Chinese Patent

PolarityTE recently announced that the China National Intellectual Property Administration (CNIPA) issued a Notification of Allowance for Chinese…
PolarityTE Submits Investigational New Drug Application for SkinTE®

PolarityTE on Monday announced the submission of an investigational new drug application (IND) to the FDA seeking authorization to…
Foldax Presents at the 2021 Transcatheter Valve Technologies Meeting

Last week, Foldax presented on the company’s innovative Tria valve at the 2021 Transcatheter Valve Technologies (TVT) meeting.…